Neumora Therapeutics to Join Needham Healthcare Conference

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, is scheduled to participate in the 25th Annual Needham Virtual Healthcare Conference. This event provides a platform for the company to discuss its progress and pipeline with investors and industry professionals. The conference is a key opportunity for Neumora to highlight its advancements in developing novel therapies for neurological disorders and engage with the broader healthcare investment community.